Dr. Mitch Earleywine, Ph.D.
Chief Research Officer & Clinical Consultant (WIN)
Dr. Mitch Earleywine, PhD, Chief Research Officer and Clinical Consultant at C3, Professor of Psychology at University at Albany, State University of New York
Dr. Mitch Earleywine co-developed Integrative Ketamine Enhanced Psychotherapy (iKEP; De Leo & Earleywine, 2019). He brings an extensive research background to C3 and offers clinical consultation in support of establishing best practices in psychedelic-assisted psychotherapy.
He is an award-winning Professor of Psychology at the University at Albany, State University of New York. There he leads a research program in the Habits and Lifestyle Laboratory focusing primarily on the study of personality, drug use, and addictive behaviors. Dr. Mitch Earleywine has trained an impressive number of students over the years who have gone on to have an outstanding impact on the field of clinical psychology. He has established a publication record of at least 200 publications garnering 10,000+ citations with 24 papers with over 100 citations. Mitch is a pioneer in the field of psychology, drug research and policy having written several books on the topic. He has received several grants from the National Institute on Alcohol Abuse and Alcoholism and the Alcoholic Beverage Medical Research Foundation. He is an advisory board member of the National Organization for Reformation of Marijuana Laws (NORML).